A Study to Evaluate the Efficacy and Safety of BR1015 Combination Therapy
Status:
Recruiting
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
The objective of this clinical trial is to evaluate the efficacy and safety of BR1015
Combination therapy group in comparison with Fimasartan monotherapy group at Week 8 for
essential hypertension patients who do not adequately responded by Fimasartan 30 mg